Home > Balance Sheet > WINDLAS BIOTECH

WINDLAS BIOTECH
Net Current Assets

    Back to Balance Sheet
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹276 Cr₹260 Cr₹232 Cr₹288 Cr₹101 Cr

What is the latest Net Current Assets ratio of WINDLAS BIOTECH ?

The latest Net Current Assets ratio of WINDLAS BIOTECH is ₹276 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹276 Cr
Mar2024₹260 Cr
Mar2023₹232 Cr
Mar2022₹288 Cr
Mar2021₹101 Cr

How is Net Current Assets of WINDLAS BIOTECH Trending?

Years Net Current Assets % Change
Mar2025 ₹276 Cr
6.22
Mar2024 ₹260 Cr
11.73
Mar2023 ₹232 Cr
-19.25
Mar2022 ₹288 Cr
185.12
Mar2021 ₹101 Cr -

Compare Net Current Assets of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,595.7 Cr -1.9% -10.7% -3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-1.9%

-10.7%

-3.5%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses